Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DUO-O: A randomized phase Ill trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients
    Meeting Abstract

    Harter, P.; Bidziński, M.; Colombo, N.; Floquet, A.; Pérez, M. J. R.; Kim, J. W.; Lheureux, S.; Marth, C.; Nyvang, G. B.; Okamoto, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of maintenance olaparib for newly diagnosed, advanced ovarian cancer patients (pts) by BRCA1 or BRCA2 mutation in the phase III SOLO1 trial
    Meeting Abstract

    Friedlander, M.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adverse events (AEs) with maintenance olaparib in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): Phase III SOLO1 trial
    Meeting Abstract

    Colombo, N.; Moore, K. N.; Scambia, G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Exploratory analysis of the effect of maintenance rucaparib on postprogression outcomes in patients (pts) with platinum-sensitive recurrent ovarian carcinoma (OC) and updated safety data from the phase 3 study ARIEL3
    Meeting Abstract

    Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC)
    Meeting Abstract

    Cadoo, K. A.; Meyers, M. L.; Burger, R. A.; Armstrong, D. K.; Penson, R. T.; Gordon, M. S.; Fleming, G. F.; Moroney, J. W.; Hamilton, E. P.; Duska, L. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of veliparib incorporated into front-line platinum based cheotherpy and bevacizumab in epithelial ovarian cancer (NCT00989651): A GOG/nrg trial
    Meeting Abstract

    Armstrong, D. K.; Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Fracasso, P. M.; Walker, J. L.; Duska, L. R.; Mathews, C. A.; Chen, A. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Positron emission tomography to evaluate response in the cervix and lymph nodes after definitive chemoradiation and immunotherapy for cervical cancer patients treated on GOG 9929
    Meeting Abstract

    Mayadev, J. S.; Enserro, D.; Ghamande, S.; Moore, K.; Lin, Y.; DaSilva, D.; Aghajanian, C.; Schilder, R.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Molecular profiling and molecular classification of endometrioid ovarian carcinomas
    Journal Article

    Cybulska, P.; Da Cruz Paula, A.; Tseng, J.; Leitao, M. M. Jr; Bashashati, A.; Huntsman, D. G.; Nazeran, T. M.; Aghajanian, C.; Abu-Rustum, N. R.; DeLair, D. F.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer
    Journal Article

    Tewari, K. S.; Burger, R. A.; Enserro, D.; Norquist, B. M.; Swisher, E. M.; Brady, M. F.; Bookman, M. A.; Fleming, G. F.; Huang, H.; Homesley, H. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save